Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Seres Therapeutics (MCRB) Assets Average: 2015-2025

Historic Assets Average for Seres Therapeutics (MCRB) over the last 10 years, with Sep 2025 value amounting to $143.6 million.

  • Seres Therapeutics' Assets Average fell 42.60% to $143.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.6 million, marking a year-over-year decrease of 42.60%. This contributed to the annual value of $249.2 million for FY2024, which is 29.54% down from last year.
  • As of Q3 2025, Seres Therapeutics' Assets Average stood at $143.6 million, which was down 6.72% from $154.0 million recorded in Q2 2025.
  • Seres Therapeutics' Assets Average's 5-year high stood at $387.0 million during Q3 2023, with a 5-year trough of $143.6 million in Q3 2025.
  • Over the past 3 years, Seres Therapeutics' median Assets Average value was $309.5 million (recorded in 2023), while the average stood at $267.1 million.
  • In the last 5 years, Seres Therapeutics' Assets Average skyrocketed by 172.29% in 2021 and then slumped by 56.56% in 2025.
  • Quarterly analysis of 5 years shows Seres Therapeutics' Assets Average stood at $375.6 million in 2021, then fell by 12.05% to $330.3 million in 2022, then rose by 9.94% to $363.1 million in 2023, then plummeted by 56.14% to $159.3 million in 2024, then slumped by 42.60% to $143.6 million in 2025.
  • Its Assets Average was $143.6 million in Q3 2025, compared to $154.0 million in Q2 2025 and $152.0 million in Q1 2025.